🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New📰Stoked to 👀 this #SysRev of #Cancer #Caregiver #FearOfRecurrence (#FCR) published in Journal of Cancer Survivorship doi.org/10.1007/s11764… We reviewed 70 #quant & #qual 📰 to evaluate caregivers' FCR: 🔹Prevalence 🔹Severity 🔹Correlates 🔹Course 🔹Impact 🔹Interventions What did we find? 🧵👇

New paper on #cancersurvivors use of relevant online #selfmanagement resources from the #PROMPTCare team which may be of interest to #surv22 attendees doi.org/10.1016/j.pec.…

Congrats to 🌟 #PhD student Verena Wu PhD whose 1st PhD 📰, a #SysRev of unmet supportive care needs in #Chinese #cancer patients & caregivers (doi.org/10.1111/ecc.13…), is a #TopCitedArticle in @WileyNews Euro Journal of #CancerCare #ProudSupervisor with Afaf Girgis AM (she/her)

1/9 More than half of all #CancerSurvivors (43+ million 🗺️) report #cancer #FearofRecurrence (#FCR) onlinelibrary.wiley.com/doi/10.1002/po… #iConquerFear is feasible & potentially efficacious online #selfhelp program that could address FCR at scale #survonc NEW 📰👇 link.springer.com/article/10.100… 🧵👇

9/12 We conducted a pilot study looking at QPL: 🔷 acceptability (survey & interview responses regarding QPL satisfaction & usefulness) 🔷 feasibility (% of eligible men given the QPL) mdpi.com/1718-7729/30/2… #PCSM

10/12 We found: 👍 acceptability: men with #prostatecancer were generally satisfied with the QPL & found it to be a useful tool to guide their consultations with the urologist 👎 feasibility: only 18% of eligible men were given a QPL mdpi.com/1718-7729/30/2… #PCSM

11/12 the low % of men given a QPL may have been b/c urologists had to get study consent before giving out the QPL OR worry the QPL would: ⬆️ men’s anxiety❌ adversely affect the doctor-patient dynamic ❌ push men towards one treatment ❌ It didn't! mdpi.com/1718-7729/30/2… #PCSM

UNSW researchers collaborating with POCOG are seeking expert consensus on a proposed clinical pathway for fear of cancer recurrence - more information and sign up available at buff.ly/3ZEblYp (HC230052 V1, 20/3/23)

Are you an #OzOnc #HCP? help us develop a consensus clinical pathway for fear of cancer recurrence - scan #QRcode below or click the link: unsw.au1.qualtrics.com/jfe/form/SV_00… #FCR #PsyOnc #SuppOnc COSA Cancer Australia Cancer Institute NSW CNSA CancerCouncilOz

Afaf Girgis AM (she/her) Verena Wu PhD UNSW Medicine & Health UNSW South West Sydney Clinical Campuses Ingham Institute for Applied Medical Research Congratulations Dr Verena Wu PhD! 🎉👏🥂 It’s been a honour being part of your PhD journey along with Afaf Girgis AM (she/her) Looking forward to seeing what great things you achieve in future 💫

Thank you so much Afaf Girgis AM (she/her) and A/Prof Ben Smith, PhD (he/him) for your wonderful support and guidance throughout my PhD! I'm so happy we got to celebrate together with my family. Looking forward to the next chapter.

Yay! I’m very excited to collaborate with A/Prof Carolyn Ee MBBS CanRevive Inc. 更生會 A/Prof Ben Smith, PhD (he/him) POCOG Jia (Jenny) Liu MD PhD + team on this Sydney Health Partners #impsci pilot grant which will explore the equitable implementation of a #fearofrecurrence clinical pathway among Chinese-speaking #cancersurvivors

An honour to present a clinical pathway for #Cancer #FearofRecurrence at #IPOS2024 on behalf of an awesome team. For anyone who's interested you'll be able to read more in Journal of Cancer Survivorship soon! Thanks to Cancer Institute NSW for their support & to all those who contributed to this work #PsyOnc

Is #fearofrecurrence all about negatives? Well research says it’s also about exploring #positives: enhanced health awareness, strengthened relationships, resilience and revaluation of life goals. #IPOS2024